Ascelia Pharma AB
F:7ZA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Ascelia Pharma AB
F:7ZA
|
SE |
|
Takeda Pharmaceutical Co Ltd
F:TKD
|
JP |
|
S
|
Scholastic Corp
F:SL1
|
US |
|
U
|
Upwork Inc
DUS:UP2
|
US |
|
ZoomInfo Technologies Inc
F:ZOM
|
US |
|
S
|
Smartone Telecommunications Holdings Ltd
XBER:SMA
|
HK |
|
R
|
Rheinmetall AG
XMUN:RHM
|
DE |
|
Rexel SA
F:E7V
|
FR |
|
F
|
Footshop as
PSE:FTSHP
|
CZ |
|
Erie Indemnity Co
F:EI2
|
US |
Wall St Price Targets
7ZA Price Targets Summary
Ascelia Pharma AB
According to Wall Street analysts, the average 1-year price target for
7ZA is 0.532 EUR with a low forecast of 0.457 EUR and a high forecast of 0.621 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 7ZA's stock price target?
Price Target
0.532
EUR
According to Wall Street analysts, the average 1-year price target for
7ZA is 0.532 EUR with a low forecast of 0.457 EUR and a high forecast of 0.621 EUR.